Image thumbnail

Breakthrough Study Shows SEBclausii™ Supports Allergy Relief & Immune Health

Breakthrough Study Shows SEBclausii™ Supports Allergy Relief & Immune Health

A groundbreaking clinical trial reveals that SEBclausii™ (Alkalihalobacillus clausii 088AE) promotes significant relief from acute allergic rhinitis symptoms and supports immune health, adding to its already impressive benefits for gut support.  

New Clinical Evidence 

A recently published randomized, double-blind, placebo-controlled clinical trial followed 40 participants (ages 18-65) with acute allergic rhinitis over a four-week period. 

The results? SEBclausii™ supported allergy symptom relief, immune function and overall respiratory comfort. 

Key Findings  

SEBclausii™ supplementation was found to support 

  • Resolution of coughing and sneezing 
  • Reduction in runny nose (rhinorrhea) 
  • Alleviation of nasal stuffiness and itching 
  • Decrease in itchy and watery eyes 

Measurable Results 

The study used standardized scoring systems to track symptom improvements. The SEBclausii™ group showed significantly greater reductions in symptom scores when compared to the control group, highlighting its effectiveness. 

Support for Immune Health 

Beyond allergy symptom relief, SEBclausii™ promoted positive changes in immune cell levels and markers, supporting the body’s natural defense mechanisms against allergic reactions. 

As gut health and immune function are closely linked, the ability of SEBclausii™ to support a balanced gut microbiome may have broader implications for immune resilience beyond seasonal allergies. 

Well-Tolerated  

SEBclausii™ was well-tolerated with no adverse effects, reinforcing its safety for allergy symptom support. Unlike pharmaceutical interventions that may cause drowsiness or other unwanted side effects, SEBclausii™ provides a cleaner approach to respiratory wellness. 

Beyond Allergies 

And SEBclausii™ isn’t just for allergies. A 2021 study demonstrated its effectiveness in addressing antibiotic-associated diarrhea (AAD) symptoms in children, adolescents and adults, and supporting overall gut health. 

The clinical study showed that SEBclausii™  

  • Reduced stool frequency  
  • Shortened duration of unformed stools 
  • Decreased bloating, abdominal discomfort and flatulence 

What Makes SEBclausii™ Unique 

Unlike traditional probiotics, spore-forming SEBclausii™ withstands acidic gastrointestinal conditions for better survival and gut colonization. Its natural resilience means it withstands processing, manufacturing, and storage without refrigeration, making it a cost-effective, reliable choice for a variety of supplements and functional foods and beverages. 

Regulatory Standout 

SEBclausii™ is the only Bacillus clausii strain with an FDA GRAS (Generally Recognized as Safe) No Objections Letter, ensuring its safety and efficacy.  

It has also been granted an NPN (Natural Product Number) and the following approved claims from Health Canada: 

  • Helps reduce the symptoms related to antibiotic-associated diarrhea  
  • Source of probiotics  
  • Could promote a favorable gut flora  
  • Helps support the maintenance of digestive health 

The Takeaway 

With its demonstrated ability to promote allergy relief, support a resolution in antibiotic-associated diarrhea symptoms, and promote gut and immune health, SEBclausii™ is a powerful addition to formulations targeting respiratory, digestive and immune wellness. 

Ready to make SEBclausii™ part of your next innovation? Contact us today!